Use of antibodies in lymphocyte secretions for detection of subclinical tuberculosis infection in asymptomatic contacts

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 6, 2004, Pages 1022-1027

  Raqib, Rubhana ^a,d   Kamal, S M Mostafa ^b   Rahman, M Jubayer ^a   Rahim, Zeaur ^a   Banu, Sayera ^a   Bardhan, Pradip K ^a   Chowdhury, Fahima ^a   Ara, Gul ^a   Zaman, K ^a   Breiman, Robert F ^a   Andersson, Jan ^c   Sack, David A ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b National Institute of Diseases of Chest and Hospital   (Bangladesh)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; BACTERIUM DETECTION; BCG VACCINATION; CELL SECRETION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULIN TEST; TUBERCULOSIS;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CELLS, CULTURED; IMMUNOGLOBULIN G; LYMPHOCYTES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 9144225576     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.6.1022-1027.2004     Document Type: Article

References (28)

1. Al Zahrani, K., H. Al Jahdali, and D. Menzies. 2000. Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am. J. Respir. Crit. Care Med. 162:1419-1422.
2. Arend, S. M., A. C. F. Engelhard, G. Groot, K. de Boer, P. Andersen, T. H. M. Ottenhoff, and J. T. van Dissel. 2001. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin. Diagn. Lab. Immunol. 8:1089-1096.
3. Behr, M. A., and P. M. Small. 1997. Has BCG attenuated to impotence? Nature 389:133-134.
4. Cohn, D. L. 2000. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control. Clin. Infect. Dis. 31:120-124.
5. Comstock, G. W. 1975. Frost revisited: the modern epidemiology of tuberculosis. Am. J. Epidemiol. 101:363-382.
6. Comstock, G. W. 1988. Identification of an effective vaccine against tuberculosis. Am. Rev. Respir. Dis. 138:479-480.
7. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. W.H.O. Global Surveillance and Monitoring Project. JAMA 282:677-686.
8. Ewer, K., J. Decks, L. Alvarez, G. Bryant, S. Waller, P. Andersen, P. Monk, and A. Lalvani. 2003. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361:1168-1173.
9. Fine, P. E., J. A. Sterne, J. M. Ponnighaus, and R. J. Rees. 1994. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344:1245-1249.
10. Grzybowski, S., G. D. Barnett, and K. Styblo. 1975. Contacts of cases of active pulmonary tuberculosis. Bull. Int. Union Tuberc. 50:90-106.
11. Hart, P. D., I. Sutherland, and J. Thomas. 1967. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines. Tubercle 48:201-210.
12. Hirsch, C. S., Z. Toossi, C. Othieno, J. L. Johnson, S. K. Schwander, S. Robertson, R. S. Wallis, K. Edmonds, A. Okwera, R. Mugerwa, P. Peters, and J. J. Ellner. 1999. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180:2069-2073.
13. Holden, M., M. R. Dubin, and P. H. Diamond. 1971. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N. Engl. J. Med. 285:1506-1509.
14. Huebner, R. E., M. F. Schein, and J. B. Bass. 1993. The tuberculin skin test. Clin. Infect. Dis. 17:968-975.
15. International Council for Standardization in Haematology, Expert Panel on Blood Rheology. 1993. ICSH recommendations for measurement of erythrocyte sedimentation rate. J. Clin. Pathol. 46:198-203.
16. Judson, F. N., and R. A. Feldman. 1974. Mycobacterial skin tests in humans 12 years after infection with Mycobacterium marinum. Am. Rev. Respir. Dis. 109:544-547.
17. Lalvani, A., P. Nagvenkar, Z. Udwadia, A. A. Pathan, K. A. Wilkinson, J. S. Shastri, K. Ewer, A. V. S. Hill, A. Mehta, and C. Rodrigues. 2001. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis. 183:469-477.
18. Lalvani, A., A. A. Pathan, H. Durkan, K. A. Wilkinson, A. Whelan, J. J. Decks, W. H. Recce, M. Latif, G. Pasvol, and A. V. Hill. 2001. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357:2017-2021.
19. Ministry of Health and Family Welfare, Government of Bangladesh. 1995. National guidelines for tuberculosis control. Government of Bangladesh, Dhaka, Bangladesh.
20. Nash, D. R., and J. E. Douglass. 1980. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest 77:32-37.
21. Orme, I. M., and F. M. Collins. 1984. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell. Immunol. 84:113-120.
22. Raqib, R., J. Rahman, A. K. Kamaluddin, S. M. Karaal, F. A. Banu, S. Ahmed, Z. Rahim, P. K. Bardhan, J. Andersson, and D. A. Sack. 2003. Rapid diagnosis of active tuberculosis by detecting antibodies from lymphocyte secretions. J. Infect. Dis. 188:364-370.
23. Sousa, A. O., A. Wargnier, Y. Poinsignon, N. Simonney, F. Gerber, F. Lavergne, J. L. Hermann, and P. H. Lagrange. 2000. Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy. Tuber. Lung Dis. 80:27-33.
24. Ulrichs, T., P. Anding, S. Porcelli, S. H. E. Kaufmann, and M. E. Munk. 2000. Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect. Immun. 68:6073-6076.
25. Ulrichs, T., and S. H. Kaufmann. 2002. Mycobacterial persistence and immunity. Front. Biosci. 7:d458-d469.
26. Ulrichs, T., M. E. Munk, H. Mollenkopf, S. Behr-Perst, R. Colangeli, M. L. Gennaro, and S. H. Kaufmann. 1998. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 28:3949-3958.
27. Vekemans, J., C. Lienhardt, J. S. Sillah, J. G. Wheeler, G. P. Lahai, M. T. Doherty, T. Corrah, P. Andersen, K. P. W. J. McAdam, and A. Marchant. 2001. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect. Immun. 69:6554-6557.
28. Wu-Hsieh, B. A., C.-K. Chen, J.-H. Chang, S.-Y. Lai, C. H. H. Wu, W.-C. Cheng, P. Andersen, and T. M. Doherty. 2001. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin. Infect. Dis. 33:1336-1340.